2006 SESSION TOPICS
Pictures
Press
abstracts
P. Botti , Dept.of Structural Biology and Bioinformatics, Faculty of Medicine, CMU/UniGe
►Iontophoresis: dontrolled drug delivery For improving therapeutic Efficacy
Y. Kalia , School of Pharmaceutical Sciences, UniGe
► Innovation in pulmonary diseases
J.P Derouette , Epithelys, Geneva
► High-precision implantable intra-arterial Drug Delivery Device (IntraArt)
N. Stergiopoulos , EPFL
►Treatment of hyperpigmentation and chronic inflammation by interfering with cell surface presentation of kit-ligand
B. Wehrle-Haller , Dept. of Cellular Physiology and Metabolism, CMU/UniGe
► Innovative applications of biopolymer
nanoparticles
C. Laue
, Medipol, Lausanne
►To be announced
L. Hermitte , Anteis, Geneva
►Cationic emulsions: a new paradigm
in ocular delivery
F. Lallemand
, Novagali Pharma, France
► The GARD (Gastroesophageal Anti-Reflux
Device) a new stent to prevent recurrence of chronic reflux esophagitis
N.
Godin , Biomedix, Geneva
► MelCure
R. Lahav
, Melcure, Geneva
►Innovation in skin repair and therapy
N. Fasel
, Belskin, UniL
► Metabolic regulations through Micronutrition
& Nutrigenomics?
G.D Parisot
, Bioresearch & Partners, Monthey
► Development of innovative therapeutical
strategies to heart failure
G. Tarone
, Target Heart Biotec, Italy
►SpiderBiotech, a multimeric peptide
start-up Company
A. Giuliani
, Spiderbiotech, Italy
►Pharmacological approaches in HMGB1
related pathologies
S. Fumero
, Creabilis Therapeutics, Italy
► Detection of cancer by a blood test:
measuring circulating hRERTRNA in plasma
Ph. Anker
, OncoXL, Geneva
► Mintaka
R. Offord , Mintaka, Geneva
► SCF technology from discovery to
GMP production
H. Pellikaan
, FeyeCon, The Netherlands
B. Gauthier , Dept. of Cell Physiology and Metabolism, CMU/UniGe
►Connexin-targeted therapy of diabetes
P. Meda , Dept. of Cell Physiology and Metabolism, CMU/UniGe
►Transparent thermosensitive hydrogels
O. Jordan , School of Pharmaceutical Sciences, UniGe
►Implants for tumor treatment by hyperthermia
H. Hofmann, EPFL
►Cholesterol-producing yeast
H. Riezman , Dept. of Biochemistry, UniGe
► 3d-cardiac tissue engineering for the cell therapy of heart failure
M. Jaconi , Dept. of Pathology and Immunology, CMU/ UniGe
►Innovative pharmaceutical technologies developed by the Debio group
E. Vuaridel , Debiopharm, Lausanne Switzerland
►The battle against MRSA: find your enemy rapidly
J. Schrenzel , Clinical Microbiology Laboratory and Genomic Research Laboratory, UniGe
► Novel Functionalized Poly(lactides) for Drug Delivery
M. Möller , School of Pharmaceutical Sciences, UniGe
►Metal anticancer drug design and target identification
P. Dyson , EPFL
►Enzyme-activated photodynamic therapy
N. Lange , School of Pharmaceutical Sciences, UniGe
►Sensing with Pores: Universal Enzyme Assays and Beyond
S. Matile , School of Chemistry, UniGe
►EAdock: high accuracy docking for drug design applications
O. Michielin , Swiss Institute of Bioinformatics, UniL
► “BEACLE” and “BioLeaders”, two Japanese biotech startups looking for european partners
W. Schlegel , Fondation pour Recherches Médicales, Geneva
CMU: Centre Médical Universitaire, UniGe, EPFL: Ecole Polytechnique
Fédérale Lausanne,
HUG: Hôpitaux universitaires de Genève, UniGe: Université
de Genève, UniL: Université de Lausanne